Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608842 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Study for the Treatment of Superficial Lipomas
A Phase 2 study of Lipoma, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
- 7
- Study locations
NCT00608842: Completed Phase 2 study of Lipoma, sponsored by Kythera Biopharmaceuticals.
NCT00608842 is a Phase 2 study of Lipoma that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 62 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608842, a Phase 2 study of Lipoma, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this research is to compare the safety and effectiveness of 3 different concentrations of deoxycholic acid for injection against a placebo in the treatment of superficial lipomas.
Primary Outcome
Severity of AEs was determined using the following scale: Mild: The participant was aware of a sign or symptom, but it was easily tolerated; Moderate: Discomfort or interference with usual activity; Severe: Incapacitating, with inability to engage in usual activity. The investigator determined the relationship of each AE to the administration of study material by answering the question: "Was there a reasonable possibility that the event may have been caused by treatment with study material?" A
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Deoxycholic Acid Injection
Study Locations (7)
Alabama
- Gary D. Monheit, M.D. - Birmingham
California
- Stacy R. Smith - San Diego
Michigan
- Steven Grekin, D.O. - Warren
Nebraska
- Joel Schlessinger, M.D. - Omaha
New Jersey
- David J. Goldberg, M.D. - Westwood
New York
- Neil S. Sadick, M.D. - New York
Tennessee
- Michael H. Gold, M.D. - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
What the finished NCT00608842 record still lists
NCT00608842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Lipoma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00608842 lists 7 locations in 7 states (Alabama, California, Michigan).
Frequently Asked Questions
What is clinical trial NCT00608842 about?
NCT00608842 is a clinical study titled "Phase 2 Study for the Treatment of Superficial Lipomas". The purpose of this research is to compare the safety and effectiveness of 3 different concentrations of deoxycholic acid for injection against a placebo in the treatment of superficial lipomas.
What is the current status of trial NCT00608842?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2007-11. Estimated completion is 2010-01.
What conditions does trial NCT00608842 study?
This clinical trial studies the following conditions: Lipoma.
What interventions are being tested in trial NCT00608842?
The interventions under investigation include: Placebo (DRUG), Deoxycholic Acid Injection (DRUG).
Who is sponsoring clinical trial NCT00608842?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00608842 being conducted?
This trial has 7 study locations across Alabama, California, Michigan, Nebraska, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00608842's enrollment target sits among peer trials
62 1016th of 2000 higher than 975 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia